Bemnifosbuvir (AT-511) is a potent and orally active HCV viral replication inhibitor. Bemnifosbuvir is highly effective in the control of SARS-CoV-2 (COVID-19) infection in vitro (EC90=0.47 µM). Bemnifosbuvir has pangenotypic antiviral activity[1][2][3].
Molecular Weight:
581.53
Purity:
99.00
CAS Number:
[1998705-64-8]
Formula:
C24H33FN7O7P
Target:
HCV,SARS-CoV
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted